PDUFA dates August 2018: FDA calendar and catalysts.
0 PDUFA dates fell in August 2018. The FDA calendar also recorded 6 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
PDUFA dates in August 2018
No PDUFA dates are disclosed for this period as of November 16, 2026.
Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months
August 2018: other FDA decisions and filings
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| August 2, 2018 | Tigecycline (tigecycline) | AMRX | FDA approval | — | Approved | openFDA Drugs@FDA |
| August 7, 2018 | Orkambi (ivacaftor; lumacaftor) | VRTX | FDA approval | — | Approved | openFDA Drugs@FDA |
| August 8, 2018 | Soluprep S (chlorhexidine gluconate; isopropyl alcohol) | SOLV | FDA approval | — | Approved | openFDA Drugs@FDA |
| August 22, 2018 | Eysuvis (loteprednol etabonate) | ALC | FDA approval | — | Approved | openFDA Drugs@FDA |
| August 30, 2018 | Pifeltro (doravirine) | MRK | FDA approval | — | Approved | openFDA Drugs@FDA |
| August 30, 2018 | Delstrigo (doravirine; lamivudine; tenofovir disoproxil fumarate) | MRK | FDA approval | — | Approved | openFDA Drugs@FDA |
August 2018: dated readouts
No events in this view.
Questions
What PDUFA dates are in August 2018?
0 PDUFA dates fell in August 2018. The FDA calendar also recorded 6 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
Can these dates change?
Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.